SCHEMBL17189461

SCHEMBL17189461

c1ccc(-n2c3ccccc3c3cc(-c4cccc(-c5ccc6c(c5)c5ccccc5n6-c5cccc6c5oc5ccccc56)c4)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ATM Q13315 1/20 0.43
PLA2G2A P14555 4/20 0.38
PLA2G4A P47712 4/20 0.38
PLA2G10 O15496 1/20 0.38
ALOX5 P09917 2/20 0.37
ALDH1A1 P00352 5/20 0.35
PPARG P37231 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
PRKDC P78527 2/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
POLB P06746 2/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GGPS1 O95749 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25941172 0.98 L3MBTL1 (0.43) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL10331542 0.98 KDM4E (0.45) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL11885005 0.98 KDM4E (0.45) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL10331549 0.98 KDM4E (0.45) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL10331503 0.98 KDM4E (0.45) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL10331653 0.98 KDM4E (0.45) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL16804063 0.96 KDM4E (0.44) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL10038498 0.95 L3MBTL1 (0.43) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL21481376 0.95 KDM4E (0.40) L3MBTL1KDM4EATMPLA2G2APLA2G4A
SCHEMBL15625343 0.95 KDM4E (0.40) L3MBTL1KDM4EATMPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
EP-2933851-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2017-05-10 EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
EP-2933851-A1 ORGANIC ELECTRICAL FIELD LIGHT-EMITTING ELEMENT Nippon Steel & Sumikin Chemical Co., Ltd. (JP) 2015-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 L3MBTL1 74/4885KDM4E 1228/4885ATM 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.